| Product Code: ETC7916856 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia saw a shift in nucleic acid testing-NAT instrumentation import shipments with top exporters being Germany, Austria, Netherlands, China, and Estonia. The Herfindahl-Hirschman Index (HHI) indicated a decrease in market concentration from high to moderate in 2024, reflecting a more diversified import landscape. Despite a negative growth rate of -14.01% in 2024, the compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 6.74%, highlighting a steady expansion in the market over the past few years. This data suggests a dynamic market for NAT instrumentation in Latvia with evolving trade patterns and growth opportunities.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Nucleic Acid Testing-NAT Instrumentation Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Nucleic Acid Testing-NAT Instrumentation Market - Industry Life Cycle |
3.4 Latvia Nucleic Acid Testing-NAT Instrumentation Market - Porter's Five Forces |
3.5 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Latvia Nucleic Acid Testing-NAT Instrumentation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Latvia |
4.2.2 Growing awareness about the importance of early disease detection |
4.2.3 Technological advancements in nucleic acid testing instruments |
4.3 Market Restraints |
4.3.1 High initial investment costs associated with nucleic acid testing instrumentation |
4.3.2 Limited reimbursement policies for nucleic acid testing procedures in Latvia |
5 Latvia Nucleic Acid Testing-NAT Instrumentation Market Trends |
6 Latvia Nucleic Acid Testing-NAT Instrumentation Market, By Types |
6.1 Latvia Nucleic Acid Testing-NAT Instrumentation Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F |
6.1.4 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Ligase Chain Reaction (LCR), 2021- 2031F |
6.1.5 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Transcriptionmediated Amplification (TMA), 2021- 2031F |
6.1.6 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Whole Genome Sequencing and Others, 2021- 2031F |
6.2 Latvia Nucleic Acid Testing-NAT Instrumentation Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Disease Diagnosis, 2021- 2031F |
6.2.3 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Forensic Testing, 2021- 2031F |
6.2.4 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Personalized Medicine, 2021- 2031F |
6.2.5 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Latvia Nucleic Acid Testing-NAT Instrumentation Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Speciality Clinics, 2021- 2031F |
6.3.4 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Diagnostic Centres, 2021- 2031F |
6.3.5 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.3.6 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Nucleic Acid Testing-NAT Instrumentation Market Import-Export Trade Statistics |
7.1 Latvia Nucleic Acid Testing-NAT Instrumentation Market Export to Major Countries |
7.2 Latvia Nucleic Acid Testing-NAT Instrumentation Market Imports from Major Countries |
8 Latvia Nucleic Acid Testing-NAT Instrumentation Market Key Performance Indicators |
8.1 Adoption rate of nucleic acid testing technology in healthcare facilities |
8.2 Number of new product launches in the nucleic acid testing instrumentation market |
8.3 Rate of utilization of nucleic acid testing instruments in routine diagnostic procedures |
9 Latvia Nucleic Acid Testing-NAT Instrumentation Market - Opportunity Assessment |
9.1 Latvia Nucleic Acid Testing-NAT Instrumentation Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Latvia Nucleic Acid Testing-NAT Instrumentation Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Latvia Nucleic Acid Testing-NAT Instrumentation Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Latvia Nucleic Acid Testing-NAT Instrumentation Market - Competitive Landscape |
10.1 Latvia Nucleic Acid Testing-NAT Instrumentation Market Revenue Share, By Companies, 2024 |
10.2 Latvia Nucleic Acid Testing-NAT Instrumentation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here